SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is currently a focal point for investors debating between a long-term growth narrative fueled by drone defense contracts and short-term volatility driven by heavy dilution concerns and active short selling. The community remains sharply divided, with bulls pointing to the company's backlog and strategic sector position while bears emphasize the ongoing downward trend and the impact of frequent share offerings on price action.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Mining is trending as investors aggressively reposition into AI infrastructure providers that control critical power capacity, with community sentiment buoyed by recent high-value lease agreements and institutional bullishness. Traders are closely monitoring key support levels and volume signals as the stock navigates a volatile sector-wide re-rating fueled by the urgent race to secure megawatt capacity for hyperscale compute buildouts.

Block, Inc. engages in creating ecosystems for distinct customer audiences. It operates through the following segments: Square and Cash App. The Square segment provides payment services, software solutions, hardware, and financial services to sellers. The Cash App segment includes the financial tools available to individuals within the mobile Cash App, including peer-to-peer payments, bitcoin and stock investments. The company was founded by Jack Patrick Dorsey and James Morgan McKelvey in February 2009 and is headquartered in Oakland, CA.

Block Inc - Ordinary Shares - Class A

Block Inc

Block is trending after the company announced a significant workforce reduction of 40% as part of a strategic pivot to lean, AI-native operations, driving a surge in share price despite a revenue miss. The community is actively debating whether this margin-focused restructuring signals long-term profitability or reflects underlying distress and competitive pressure from rivals like Toast and Shop.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing volatile trading as investors debate whether the current valuation is supported by its role as a critical bottleneck in the AI infrastructure supply chain. The community remains sharply divided, with bulls highlighting its proprietary wafer-level burn-in technology as essential for long-term AI hardware reliability, while bears argue the current market cap is detached from fundamentals and vulnerable to sharp corrections.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

ATAI is trending as investors weigh potential Phase 3 catalysts against recent volatility, with the community actively debating whether the stock's performance reflects genuine institutional accumulation or lingering frustration over clinical trial timelines and stock price consolidation. Discussion remains heavily focused on the company's long-term pipeline potential, the strategic impact of recent U.S. executive-level support for psychedelic research, and the perceived disconnect between the company's clinical progress and its current market valuation.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is currently a focal point for investors debating the resilience of defensive dividend stocks amidst broader market rotation and shifting consumer spending habits. The community is actively discussing the stock's technical support levels and strategic outlook, with contrasting views on whether the current valuation represents a generational buying opportunity or a signal of deeper structural headwinds for the fast-food sector.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors debate the impact of its newly launched proprietary prediction market exchange, DKeX, against competitive pressures from broader market entrants. While the community is split between bullish sentiment regarding the company's long-term dominance in the prediction space and frustration over recent stock volatility, active discussions remain heavily focused on how these predictive offerings will integrate with existing sportsbook operations and influence future revenue growth.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending following a massive fiscal year earnings beat, where revenue growth and a strong $1.2B funded backlog highlighted the sustained demand for counter-drone and autonomous systems. The community is actively debating the company's long-term valuation versus its forward guidance, while traders are closely monitoring how this momentum impacts the broader defense and robotics sector.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is gaining significant market attention as momentum builds ahead of critical clinical data updates for its eczema and alopecia programs. Investors are closely watching the stock for potential signs of an M&A catalyst, with ongoing community discussion highlighting management's recent financing moves and the stock's potential as a buyout target in the dermatology space.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is facing significant downward pressure as investors weigh a combination of slowing growth, regulatory scrutiny regarding child safety, and ongoing securities litigation. While some bulls are betting on the platform's long-term monetization potential and recent share buyback program to stabilize the price, the broader community remains deeply divided, with many traders focusing on technical breakdowns and questioning the sustainability of the company's current business model.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GSK plc (GSK) Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share

GSK plc (GSK) Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share...

FDA Expands IONS' Tryngolza Label to Treat Severe Hypertriglyceridemia

Ionis wins FDA approval to expand Tryngolza to severe hypertriglyceridemia, opening a broader market as the first approved treatment for the condition. 

GSK Commences Tender Offer To Acquire Nuvalent For $124 Per Share

(RTTNews) - GSK plc (GSK) said Wednesday that its indirect wholly-owned subsidiary, Harmony Row Acquisition Co., has commenced a tender offer to acquire all outstanding shares of Nuvalent Inc. (NUVL) for $124.00 per share in cash...

Top Analyst Reports for Micron Technology, Coca-Cola & Arista Networks

MU, KO and ANET headline Zacks' latest analyst reports, with AI demand, pricing gains and networking expansion driving the outlook.

Brains, AI Imaging, and Breakthrough Antibiotics Ignite Investor Buzz

The healthcare and biotechnology sector continues to generate a steady stream of meaningful catalysts as companies advance novel therapies, secure regulatory milestones, strengthen intellectual property portfolios, and expand commercialization efforts. Recent developments from CervoMed (NASDAQ:CRVO), Butterfly Network (NYSE:BFLY), NeOnc (NASDAQ:NTHI), Spero Therapeutics (NASDAQ:SPRO), GSK (NYSE:GSK), and IceCure Medical (NASDAQ:ICCM) highlight several emerging themes shaping the sector, including neurodegenerative disease treatment, AI-powered diagnostics, antimicrobial resistance, minimally invasive cancer care, and synthetic biology.

Biogen to Strengthen Immunology Pipeline With $1B RayThera Buyout

BIIB is set to acquire RayThera for up to $1 billion, adding anti-inflammatory candidates that could expand its immunology pipeline and future growth.

GSK's Utebzi Wins FDA Nod for Complicated Urinary Tract Infections

GSK wins FDA approval for Utebzi, the first oral carbapenem for complicated UTIs, further expanding its anti-infectives portfolio.

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

GSK plc (LSE/NYSE: GSK) and Spero Therapeutics (Nasdaq: SPRO) today announced that the US Food and Drug Administration (FDA) has approved Utebzi, an oral antibiotic for the treatment of complicated urinary tract infections (cUTIs) including pyelonephritisi, caused by certain susceptible pathogensii...

GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs

FDA approves GSK and SPRO's Utebzi, the first oral carbapenem for cUTIs. Launch planned for late 2026. See market reaction.read more...

The Zacks Analyst Blog Highlights Gilead Sciences, Merck and GSK

Gilead Sciences won FDA acceptance for a filing that could expand Yeztugo into a once-weekly oral HIV prevention option, broadening its HIV portfolio.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

GSK Plc - ADR

NUVL Stock Surges 39% Premarket – Why Is GSK Buying This Boston-Based Oncology Company?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$1.24	--	--	N/A
Q1 '26	$1.15	$1.26	8.75%	BEAT
Q4 '25	$0.64	$0.70	8.50%	BEAT
Q3 '25	$1.26	$1.46	15.86%	BEAT
Q2 '25	$1.17	$1.24	5.58%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

GSKGlaxosmithkline plc - ADR

Upcoming Earnings: Q2 '26

Historical Earnings

Latest GSK News